Literature DB >> 13202237

Cortisone treatment in advanced carcinoma of the prostate.

G M MILLER, F HINMAN.   

Abstract

Entities:  

Keywords:  CORTISONE/therapeutic use; PROSTATE/neoplasms

Mesh：

Substances：

Year:  1954        PMID： 13202237     DOI： 10.1016/s0022-5347(17)67614-6

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  6 in total

1.  The results of early diagnosis of genito-urinary cancer: contemporary trends in diagnosis and treatment.

Authors:  B G CLARKE
Journal:  Can Med Assoc J       Date:  1959-12-01       Impact factor: 8.262

2.  Hormonal therapy in prostate cancer: historical approaches.

Authors:  E David Crawford
Journal:  Rev Urol       Date:  2004

3.  The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial.

Authors:  Jimmy L Zhao; Karim Fizazi; Fred Saad; Kim N Chi; Mary-Ellen Taplin; Cora N Sternberg; Andrew J Armstrong; Johann S de Bono; William T Duggan; Howard I Scher
Journal:  Clin Cancer Res       Date:  2022-03-01       Impact factor: 13.801

Review 4.  Evolution of androgen receptor targeted therapy for advanced prostate cancer.

Authors:  Yien Ning Sophia Wong; Roberta Ferraldeschi; Gerhardt Attard; Johann de Bono
Journal:  Nat Rev Clin Oncol       Date:  2014-05-20       Impact factor: 66.675

5.  The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.

Authors:  M Dowsett; R J Shearer; B A Ponder; P Malone; S L Jeffcoate
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

6.  Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.

Authors:  B A Ponder; R J Shearer; R D Pocock; J Miller; D Easton; C E Chilvers; M Dowsett; S L Jeffcoate
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.